CD274 and head and neck squamous cell carcinoma: Since early research demonstrated proof-of-principle to identify CTC PD-L1 RNA transcript expression [23] and PD-L1 surface protein expression in HNSCC [24], several studies have sought to investigate multiple immune markers expressed by CTCs as potential biomarkers.